Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of ...

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Novo Nordisk reported mixed Q3 earnings, but GLP-1 drugs contributed to revenue strength. The company also adjusted its ...

This list can have an impact on your drug coverage in 2025 and shows why this open enrollment is so important.

Third quarter sales of Novo’s in-demand obesity drug totaled $2.5 billion, roughly 81% higher than the same period in 2023 and nearly doubling the total for Lilly’s Zepbound.

Almost 16% of American adults — or about 1 in 6 — have type 1 or type 2 diabetes, the US Centers for Disease Control and ...

As a diabetes specialist, I’ve treated thousands of patients, some in Beverly Hills and some in East Los Angeles. My Beverly Hills patients live to become healthy 80- and 90-year-olds. I can’t ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as ... Older adults, especially ...

Wegovy and Ozempic drove Novo Nordisk to record bumper sales since ... Biocon (which already has large-scale peptide ...